50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)
QQQ   271.87 (-2.88%)
AAPL   142.48 (-4.91%)
MSFT   237.50 (-1.48%)
META   136.41 (-3.67%)
GOOGL   97.42 (-2.63%)
AMZN   114.80 (-2.72%)
TSLA   268.21 (-6.81%)
NVDA   122.20 (-4.05%)
NIO   15.58 (-10.10%)
BABA   79.06 (-2.38%)
AMD   64.14 (-6.17%)
T   15.53 (-1.90%)
MU   50.01 (-1.94%)
CGC   2.78 (-8.55%)
F   11.47 (-5.83%)
GE   62.73 (-2.68%)
DIS   97.45 (-1.96%)
AMC   7.10 (-7.43%)
PYPL   88.70 (-2.66%)
PFE   44.16 (-0.61%)
NFLX   239.71 (-2.24%)

ReneSola Ltd (NYSE:SOL) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

ReneSola Ltd (NYSE:SOL - Get Rating) has been given a consensus recommendation of "Moderate Buy" by the six ratings firms that are currently covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell recommendation, three have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among brokerages that have covered the stock in the last year is $9.33.

Several analysts have recently issued reports on the stock. StockNews.com lowered shares of ReneSola from a "hold" rating to a "sell" rating in a research report on Friday, June 17th. HC Wainwright reaffirmed a "buy" rating on shares of ReneSola in a report on Thursday, September 8th. Northland Securities initiated coverage on ReneSola in a report on Tuesday. They issued an "outperform" rating and a $8.00 price target for the company. TheStreet raised ReneSola from a "d+" rating to a "c-" rating in a research note on Thursday, August 18th. Finally, Raymond James decreased their target price on ReneSola from $12.50 to $10.00 and set a "strong-buy" rating for the company in a research report on Tuesday, July 12th.

Insider Buying and Selling

In related news, CFO Shah Capital Management acquired 145,000 shares of the firm's stock in a transaction on Tuesday, June 21st. The stock was bought at an average cost of $4.63 per share, with a total value of $671,350.00. Following the acquisition, the chief financial officer now directly owns 12,164,611 shares in the company, valued at $56,322,148.93. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 18.02% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On ReneSola


A number of institutional investors have recently added to or reduced their stakes in the company. Physicians Financial Services Inc. bought a new stake in ReneSola in the second quarter valued at $57,000. abrdn plc bought a new position in ReneSola in the first quarter valued at about $64,000. Envestnet Asset Management Inc. bought a new position in ReneSola in the first quarter valued at about $64,000. Verition Fund Management LLC bought a new position in ReneSola during the first quarter worth about $67,000. Finally, Cetera Advisors LLC boosted its holdings in ReneSola by 27.0% during the first quarter. Cetera Advisors LLC now owns 16,940 shares of the semiconductor company's stock worth $98,000 after buying an additional 3,600 shares during the last quarter. 38.66% of the stock is owned by institutional investors and hedge funds.

ReneSola Trading Up 0.9 %

ReneSola stock traded up $0.05 during midday trading on Tuesday, hitting $5.59. The stock had a trading volume of 1,052 shares, compared to its average volume of 618,908. The firm's fifty day moving average is $5.77 and its two-hundred day moving average is $5.44. The company has a market capitalization of $375.31 million, a PE ratio of -138.75 and a beta of 2.20. ReneSola has a 52-week low of $3.46 and a 52-week high of $9.72.

ReneSola (NYSE:SOL - Get Rating) last posted its quarterly earnings results on Wednesday, September 7th. The semiconductor company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.02 by ($0.03). ReneSola had a negative return on equity of 0.12% and a negative net margin of 5.50%. During the same period in the prior year, the company earned $0.10 earnings per share. As a group, equities research analysts predict that ReneSola will post 0.1 earnings per share for the current fiscal year.

ReneSola Company Profile

(Get Rating)

ReneSola Ltd, through its subsidiaries, develops, builds, operates, and sells solar power projects in the United States, Canada, Europe, and internationally. It operates through three segments: Solar Power Project Development, EPC Services, and Electricity Generation Revenue. The company also develops community solar gardens; and sells project rights.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in ReneSola right now?

Before you consider ReneSola, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and ReneSola wasn't on the list.

While ReneSola currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Free Email Newsletter

Complete the form below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter:

Most Read This Week

Recent Articles

Search Headlines:

Latest PodcastFed Raises Rates: 3 Stocks to Watch Newmont Mining, Walmart, AMC

Axel Merk, President and CIO of Merk Investments has three very different stocks he frames within the current market and economic conditions.

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.